Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Category: CD derivatives

February 6, 2026 CD derivatives / Other industrial use

Blue Danube PhD Symposium – BDSHC 2026

On Friday, the 13th February at 13:30 CET a group of brilliant PhD students from the Blue Danube countries (A,CZ,H, SK,

Continue reading

February 4, 2026 CD as API / CD derivatives / Pharma applications

Studies on Sleep-Deprived Animals Reveal HPBCD’s Role in Restoring Normal Neuronal Function

A study published in Proceedings of the National Academy of Sciences (https://www.pnas.org/doi/10.1073/pnas.2523438123) suggests that lack of sleep harms the fatty insulation that

Continue reading

February 3, 2026 CD derivatives / Life sciences

Studies on Sleep-Deprived Animals Reveal HPBCD’s Role in Restoring Normal Neuronal Function

A study published in Proceedings of the National Academy of Sciences (https://www.pnas.org/doi/10.1073/pnas.2523438123) suggests that lack of sleep harms the fatty

Continue reading

January 12, 2026 CD as API / CD derivatives / Drug delivery / Non-pharma applications / Pharma applications / Uncategorized

Special Issue of the 21st International Cyclodextrin Symposium

The papers from the Special Issue of the 21st International Cyclodextrin Symposium published in Carbohydrate Polymers are available (https://www.sciencedirect.com/special-issue/10BLTS8S758).  The

Continue reading

January 6, 2026 CD as API / CD derivatives / Pharma applications

Sulfonated, sulfated thioglycosides and multivalence in heparanase inhibition

Heparan sulfate (HS) analogs are synthetic oligo- and polysaccharides designed to mimic or enhance several biological properties of native HS.

Continue reading

December 23, 2025 CD as API / CD derivatives / Pharma applications

Multifunctional biomimetic nanocarriers for the treatment of atherosclerosis

Atherosclerosis (AS) has been considered a systemic disease characterized by the excessive generation of reactive oxygen species (ROS) and the

Continue reading

December 19, 2025 CD derivatives / Pharma applications

Cyclodextrin-based carriers for targeted drug delivery, a new review

This post was written by Ibrahim Hussein. Cyclodextrin-based carriers have evolved beyond their traditional role as solubilizing agents toward ligand-targeted,

Continue reading

a rat is standing on top of a plastic container
December 18, 2025 CD as API / CD derivatives / Pharma applications

Selective removal of 7-ketocholesterol by a CD-dimer, a novel atherosclerosis therapeutic candidate

The removal of the toxic oxidized cholesterol, 7-ketocholesterol (7KC), from cells through the administration of therapeutics has the potential to

Continue reading

December 15, 2025 CD as API / CD derivatives / Pharma applications

Dual activity of low-molecular-weight polymeric β-cyclodextrins against tuberculosis

/The biological properties of pβCD of different molecular weights were studied. Strikingly, only the low-molecular-weight pβCD (LMW-pβCD) displayed antibacterial activity,

Continue reading

December 4, 2025 CD derivatives / Drug delivery / Pharma applications

Novel delivery systems for Resveratrol

A novel polymer, β-cyclodextrin-epichlorohydrin-cyanoguanidine polymer (CDPC) was synthesized to evaluate its potential as an efficient carrier for the encapsulation of

Continue reading

Posts pagination

«Previous Posts 1 … 4 5 6 7 8 … 43 Next Posts»

Recent Posts

  • Self-Disinfecting Food Coatings: Light-Activated Antimicrobial Surfaces
  • Can a Cyclodextrin Really Stop Body Odor by Quorum Quenching?
  • Disruption of Lipid Sorting and Endosomal Transport in Cyclodextrin-mediated Cytotoxicity
  • 4th International Aquatic Biotechnology Symposium
  • Cyclodextrin metal-organic framework engineered titanium surface: Targeted modulation of foam cell lipid homeostasis and inflammatory resolution

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (73)
  • CD as API (352)
  • CD derivatives (428)
  • Cosmetics and toilettry (53)
  • Diagnosis (13)
  • Drug delivery (806)
  • E-ducation (63)
  • Environmental (143)
  • Events (237)
  • Food (231)
  • Gene delivery (22)
  • Household products (1)
  • Household products (5)
  • In Hungarian (4)
  • Life sciences (44)
  • Non-pharma applications (412)
  • Other industrial use (111)
  • Pharma applications (1,206)
  • Supramolecular systems (44)
  • Uncategorized (164)

Top Posts

  • Can a Cyclodextrin Really Stop Body Odor by Quorum Quenching?
  • Self-Disinfecting Food Coatings: Light-Activated Antimicrobial Surfaces
  • Disruption of Lipid Sorting and Endosomal Transport in Cyclodextrin-mediated Cytotoxicity
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • The monograph of SBECD is official in the European Pharmacopeia
  • Lanosterol eye drops for cataract treatment
  • Cyclodextrins as Multi-Functional Ingredients in Dentistry
  • Bridion® injection now approved for patients of all ages
  • OCULIS ANNOUNCES AN OVERSUBSCRIBED US$57 MILLION SERIES C FINANCING
  • Cyclodextrin metal-organic framework engineered titanium surface: Targeted modulation of foam cell lipid homeostasis and inflammatory resolution

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...